Knight Initiative News

This week on the podcast, Stanford radiology faculty Kim Butts Pauly and Raag Airan help us dive deep into the brain with focused ultrasound

In the lab of Lauren O’Connell, associate professor of biology, researchers look to amphibian species to learn how animals evolve in response to changing environments.

Our brains and digestive tracts are in constant communication. When that communication goes off the rails, research suggests diseases and disorders can result.

Stanford researchers have created a compound that relieves multiple types of pain in mice without building tolerance or causing psychoactive side effects.

The 1970s papers from Goldberg and Wurtz made ambitious mechanistic studies of higher brain functions seem feasible.

Mice learn fastest and most reliably when they experience an increase in dopamine paired with an inhibition of serotonin in their nucleus accumbens, a new study shows, helping to resolve long-standing questions about the neuromodulators’ relationship.

A new generation of researchers at Stanford’s Wu Tsai Neurosciences Institute is developing tools to modify brain activity for research and clinical applications—without drilling through the skull.

Stanford Medicine research demonstrates a new way of detecting cells implicated in the malfunctions that cause psychiatric diseases.

Academic leaders debated the future of the intersecting study of natural and artificial intelligence at Wu Tsai Neuro’s Annual Symposium

This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view that we should stop judging one another (and ourselves) for behaviors we can't control

New research from the Malenka lab reveals that reward-based learning requires the two neuromodulators to balance one another's influence.

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

Science Corporation's retinal implant, built on the research of faculty affiliate Daniel Palanker, has allowed some people who lost their central vision to read, play cards, and recognize faces.

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.

Laura Gwilliams, a Wu Tsai Neuro faculty scholar, and Brian Hie are the inaugural faculty of Stanford Data Science. Their work spans multiple disciplines but is united by the desire to explore and leverage large volumes of real-world data.

Work on human cognition by the founding director of the Wu Tsai Neuro Center for Mind, Brain, Computation and Technology was foundational for neural-network-based computational modeling 

This week we are talking with Stanford neurobiologist Lisa Giocomo, exploring the intersection of memory, navigation, and the boundaries we create between ourselves and the world around us.